TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 46 filers reported holding TYRA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $438,877 | -19.1% | 31,872 | 0.0% | 0.06% | -20.3% |
| Q2 2023 | $542,780 | -61.5% | 31,872 | -63.6% | 0.07% | -63.4% |
| Q1 2023 | $1,408,905 | +67.2% | 87,673 | -20.9% | 0.20% | +104.0% |
| Q4 2022 | $842,506 | -24.7% | 110,856 | -12.9% | 0.10% | -28.3% |
| Q3 2022 | $1,119,000 | -6.0% | 127,316 | -23.5% | 0.14% | -37.0% |
| Q2 2022 | $1,191,000 | -56.0% | 166,526 | -34.1% | 0.22% | -37.6% |
| Q1 2022 | $2,704,000 | -59.4% | 252,726 | -46.6% | 0.35% | -48.9% |
| Q4 2021 | $6,660,000 | -62.3% | 473,394 | -52.8% | 0.69% | -46.0% |
| Q3 2021 | $17,650,000 | – | 1,003,394 | – | 1.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $75,102,147 | 53.19% |
| Nextech Invest Ltd. | 2,518,582 | $42,891,451 | 14.58% |
| TCG Crossover Management, LLC | 1,989,103 | $33,874,424 | 5.56% |
| Boxer Capital, LLC | 6,448,359 | $109,816 | 5.09% |
| Fairmount Funds Management LLC | 1,416,998 | $24,131,476 | 3.40% |
| RA Capital Management | 7,236,454 | $123,236,812 | 2.33% |
| BVF INC/IL | 2,739,595 | $46,655,303 | 1.30% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $17,507,061 | 1.05% |
| Auour Investments LLC | 85,020 | $1,447,891 | 0.62% |
| Artia Global Partners LP | 45,253 | $770,659 | 0.27% |